RT @PokrajacAna: Slope of eGFR decline rules! 🤘@ABCDiab The relationship between eGFR slope and subsequent risk of vascular outcomes and…
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study. https://t.co/DO7XwpZQsE
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl – The relationship between eGFR slope and subsequent risk of vascular outcomes and all…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl – The relationship between eGFR slope and subsequent risk of vascular outcomes and all…
#OpenAccess in @DiabetologiaJnl – The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study https://t.co/cyeJ0hBUsU
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl – 'The relationship between eGFR slope and subsequent risk of vascular outcomes and al…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl – 'The relationship between eGFR slope and subsequent risk of vascular outcomes and al…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl – 'The relationship between eGFR slope and subsequent risk of vascular outcomes and al…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl – 'The relationship between eGFR slope and subsequent risk of vascular outcomes and al…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl – 'The relationship between eGFR slope and subsequent risk of vascular outcomes and al…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl – 'The relationship between eGFR slope and subsequent risk of vascular outcomes and al…
#OpenAccess in @DiabetologiaJnl – 'The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study' https://t.co/lXVcYkWQLB
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study | SpringerLink https://t.co/GWVeFTFprm
The relationship between #eGFR slope and subsequent risk of #vascular outcomes and all-cause mortality in type 2 #diabetes: the ADVANCE-ON study https://t.co/lBUuTdcgZG
RT @DiabetologiaJnl: #eGFR slope can be used in type 2 #diabetes as a surrogate endpoint for #renal outcomes, as well as to identify indivi…
#eGFR slope can be used in type 2 #diabetes as a surrogate endpoint for #renal outcomes, as well as to identify individuals at high risk of #cardiovascular disease and all-cause mortality @georgeinstitute #ESKD #CVD #T2DM 🔓 https://t.co/mELSqWOxRj #toptwee
RT @kamleshkhunti: eGFR slope in T2 #diabetes-a prognostic factor for renal endpoints & identifying individuals at high risk of cardiovascu…
RT @kamleshkhunti: eGFR slope in T2 #diabetes-a prognostic factor for renal endpoints & identifying individuals at high risk of cardiovascu…
RT @kamleshkhunti: eGFR slope in T2 #diabetes-a prognostic factor for renal endpoints & identifying individuals at high risk of cardiovascu…
RT @kamleshkhunti: eGFR slope in T2 #diabetes-a prognostic factor for renal endpoints & identifying individuals at high risk of cardiovascu…
RT @kamleshkhunti: eGFR slope in T2 #diabetes-a prognostic factor for renal endpoints & identifying individuals at high risk of cardiovascu…
RT @kamleshkhunti: eGFR slope in T2 #diabetes-a prognostic factor for renal endpoints & identifying individuals at high risk of cardiovascu…
RT @kamleshkhunti: eGFR slope in T2 #diabetes-a prognostic factor for renal endpoints & identifying individuals at high risk of cardiovascu…
RT @kamleshkhunti: eGFR slope in T2 #diabetes-a prognostic factor for renal endpoints & identifying individuals at high risk of cardiovascu…
RT @kamleshkhunti: eGFR slope in T2 #diabetes-a prognostic factor for renal endpoints & identifying individuals at high risk of cardiovascu…
eGFR slope in T2 #diabetes-a prognostic factor for renal endpoints & identifying individuals at high risk of cardiovascular disease and all-cause mortality https://t.co/0ibZXlYsUZ @LRWEUnit @DSNforumUK @youngdiab @ABCDiab @AmarPut @AbdTahrani @drpa
RT @DiabetologiaJnl: #eGFR slope can be used in type 2 #diabetes as a surrogate endpoint for #renal outcomes, as well as to identify indivi…
RT @DiabetologiaJnl: #eGFR slope can be used in type 2 #diabetes as a surrogate endpoint for #renal outcomes, as well as to identify indivi…
An annual substantial decrease in eGFR in diabetic patients proves to be a strong predictor for future diabetic kidney disease, major CV events and overall mortality. https://t.co/6znr6Uvdem
RT @DiabetologiaJnl: #eGFR slope can be used in type 2 #diabetes as a surrogate endpoint for #renal outcomes, as well as to identify indivi…
RT @DiabetologiaJnl: #eGFR slope can be used in type 2 #diabetes as a surrogate endpoint for #renal outcomes, as well as to identify indivi…
RT @DiabetologiaJnl: #eGFR slope can be used in type 2 #diabetes as a surrogate endpoint for #renal outcomes, as well as to identify indivi…
RT @DiabetologiaJnl: #eGFR slope can be used in type 2 #diabetes as a surrogate endpoint for #renal outcomes, as well as to identify indivi…
#eGFR slope can be used in type 2 #diabetes as a surrogate endpoint for #renal outcomes, as well as to identify individuals at high risk of #cardiovascular disease and all-cause mortality @georgeinstitute #ESKD #CVD #T2DM 🔓 https://t.co/mELSqX69fT https://
RT @PokrajacAna: Slope of eGFR decline rules! 🤘@ABCDiab The relationship between eGFR slope and subsequent risk of vascular outcomes and…
RT @PokrajacAna: Slope of eGFR decline rules! 🤘@ABCDiab The relationship between eGFR slope and subsequent risk of vascular outcomes and…
RT @PokrajacAna: Slope of eGFR decline rules! 🤘@ABCDiab The relationship between eGFR slope and subsequent risk of vascular outcomes and…
RT @PokrajacAna: Slope of eGFR decline rules! 🤘@ABCDiab The relationship between eGFR slope and subsequent risk of vascular outcomes and…
I’m sure #kidney people have always known it, but I am thrilled for the evidence 😊@VladoPerkovic @unicipa
Slope of eGFR decline rules! 🤘@ABCDiab The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study | SpringerLink @DamianFog @Roxytonin https://t.co/J2mmLnJ5fF
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study. https://t.co/DO7XwpZQsE